Angiotensin II has complex effects on the heart and ... Most important among these are selectivity for the angiotensin type 1 receptor and a lack of agonist activity at this receptor site.

Two groups of drugs, the ACE inhibitors and angiotensin II type 1 receptor antagonists (angiotensin receptor blockers [ARBs]) have been developed with the aim of improving clinical outcomes by ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.

STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding AB (STO:VICO) ("Vicore"), unlocking the potential of a new class of drug candidates, angiotensin II type 2 receptor agonists ...

Erectile dysfunction is rarely a side effect, occurring in less than 1% of patients ... after 2 years on the alpha-blocker Cardura. Drugs known as ARBs (angiotensin II receptor blockers, like ...

This medication is an angiotensin II receptor antagonist, prescribed for high blood pressure. This medication is an angiotensin II receptor blocker (ARB), prescribed for high blood pressure either ...

Sparsentan, which in 2023 was approved for IgA nephropathy, is a non-immunosuppressive, oral medication that selectively blocks the angiotensin II type 1 receptor and the endothelin-A receptor to ...

They lower the effect of angiotensin II by blocking the conversion ... inhibitor. GLP-1 receptor agonists offer the following benefits for those with type 2 diabetes and CKD: Lower blood sugar ...

STOCKHOLM, SE / ACCESS Newswire / May 2, 2025 /Vicore Pharma Holding AB (STO:VICO), unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced ...